Abattis Bioceuticals Corp. (ATTBF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 24, 2025, 4:00 PM EDT
Abattis Bioceuticals Balance Sheet
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | 2010 - 2014 |
---|---|---|---|---|---|---|
Period Ending | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | Sep '15 Sep 30, 2015 | 2010 - 2014 |
Cash & Equivalents | 2.02 | 4.06 | 0.53 | 0.04 | 0.16 | Upgrade
|
Short-Term Investments | - | 5.03 | - | - | - | Upgrade
|
Trading Asset Securities | 0.38 | - | - | - | 0.09 | Upgrade
|
Cash & Short-Term Investments | 2.4 | 9.1 | 0.53 | 0.04 | 0.25 | Upgrade
|
Cash Growth | -73.59% | 1630.72% | 1265.65% | -84.65% | -77.42% | Upgrade
|
Accounts Receivable | 0.18 | - | 0 | 0 | 0 | Upgrade
|
Other Receivables | - | 0.57 | 0.13 | 0.04 | 0.04 | Upgrade
|
Receivables | 0.18 | 0.57 | 0.13 | 0.04 | 0.04 | Upgrade
|
Inventory | 0.27 | 0.03 | - | - | - | Upgrade
|
Prepaid Expenses | 0.76 | 0.77 | 0.03 | 0.01 | 0.05 | Upgrade
|
Restricted Cash | - | - | - | - | 0.01 | Upgrade
|
Total Current Assets | 3.6 | 10.46 | 0.68 | 0.09 | 0.35 | Upgrade
|
Property, Plant & Equipment | 0.76 | 0.73 | 0.53 | 0.15 | 0.17 | Upgrade
|
Long-Term Investments | 0.05 | 0.21 | - | - | - | Upgrade
|
Goodwill | 3.16 | - | - | - | - | Upgrade
|
Other Intangible Assets | 11.69 | - | - | 1.03 | 1.1 | Upgrade
|
Other Long-Term Assets | - | - | 0 | 0 | 0 | Upgrade
|
Total Assets | 19.26 | 11.4 | 1.21 | 1.27 | 1.61 | Upgrade
|
Accounts Payable | 0.22 | 0.22 | 0.23 | 0.61 | 0.72 | Upgrade
|
Accrued Expenses | 0.04 | 0.08 | 0.21 | 0.38 | 0.4 | Upgrade
|
Current Portion of Leases | 0.03 | - | - | - | - | Upgrade
|
Other Current Liabilities | 4.62 | - | - | 0.04 | 0.02 | Upgrade
|
Total Current Liabilities | 4.91 | 0.3 | 0.44 | 1.03 | 1.14 | Upgrade
|
Long-Term Debt | - | - | - | 0.03 | - | Upgrade
|
Long-Term Leases | 0.12 | - | - | - | - | Upgrade
|
Other Long-Term Liabilities | 3.56 | - | - | - | - | Upgrade
|
Total Liabilities | 8.59 | 0.3 | 0.44 | 1.06 | 1.14 | Upgrade
|
Common Stock | 114.45 | 108.84 | 22.1 | 14.71 | 12.44 | Upgrade
|
Retained Earnings | -101.71 | -99.8 | -22.74 | -15.15 | -12.98 | Upgrade
|
Comprehensive Income & Other | -1.67 | 2.44 | 2.16 | 1.11 | 1.4 | Upgrade
|
Total Common Equity | 11.08 | 11.49 | 1.52 | 0.67 | 0.86 | Upgrade
|
Minority Interest | -0.41 | -0.39 | -0.75 | -0.46 | -0.38 | Upgrade
|
Shareholders' Equity | 10.67 | 11.1 | 0.77 | 0.21 | 0.48 | Upgrade
|
Total Liabilities & Equity | 19.26 | 11.4 | 1.21 | 1.27 | 1.61 | Upgrade
|
Total Debt | 0.15 | - | - | 0.03 | - | Upgrade
|
Net Cash (Debt) | 2.25 | 9.1 | 0.53 | 0.01 | 0.25 | Upgrade
|
Net Cash Growth | -75.25% | 1630.72% | 6853.81% | -96.98% | -77.42% | Upgrade
|
Net Cash Per Share | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | Upgrade
|
Filing Date Shares Outstanding | 476.05 | 476.05 | 165.83 | 110.01 | 74.7 | Upgrade
|
Total Common Shares Outstanding | 476.05 | 425.36 | 165.83 | 110.01 | 74.7 | Upgrade
|
Working Capital | -1.31 | 10.16 | 0.24 | -0.94 | -0.79 | Upgrade
|
Book Value Per Share | 0.02 | 0.03 | 0.01 | 0.01 | 0.01 | Upgrade
|
Tangible Book Value | -3.77 | 11.49 | 1.52 | -0.36 | -0.24 | Upgrade
|
Tangible Book Value Per Share | -0.01 | 0.03 | 0.01 | -0.00 | -0.00 | Upgrade
|
Land | 0.17 | 0.17 | 0.17 | - | - | Upgrade
|
Machinery | 0.37 | 0.46 | 0.48 | 0.22 | 0.23 | Upgrade
|
Leasehold Improvements | 0.09 | 0.08 | 0.08 | 0.08 | 0.03 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.